OCD Trial, Recruiting NCT07561528 Sponsor: Istanbul University - Cerrahpasa Condition: OCD
Back to Ocd

OCD Trial, Recruiting

NCT07561528
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 18 and 65 years old
  • People who have been diagnosed with Obsessive-Compulsive Disorder (OCD) based on standard diagnostic criteria known as DSM-5
  • People whose OCD has not responded well to at least one antidepressant medication from a group called SSRIs, taken at the right dose for long enough
  • People whose OCD symptoms score at 20 or higher on a standard OCD severity rating scale called the Y-BOCS, measured at the start of the study
  • People whose current medications have not changed in the past 2 months, and who are willing to keep their doses stable throughout the study
  • People who have given informed consent to participate and have no medical reasons that would make a brain stimulation treatment called TMS unsafe for them

Who may not be able to join:

  • People who have a serious neurological condition or a degenerative brain disease
  • People who have any condition that raises their risk of having a seizure
  • People who have a cochlear implant, metal implants in the head or neck area, a cardiac pacemaker, deep brain stimulation device, or a vagus nerve stimulator
  • People who have had brain surgery in the past
  • People who have any other medical reason that would make TMS (a type of brain stimulation) unsafe for them (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +905069898506

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istanbul University - Cerrahpasa
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
1 February 2027

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) Total Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov